ArticleNature genetics2025

NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodeling.

Xiaodong Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.